Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

AdaptHealth Affirms FY2025 Sales Guidance of $3.180B-$3.260B vs $3.225B Est

Author: Benzinga Newsdesk | November 04, 2025 07:07am
AdaptHealth (NASDAQ:AHCO) affirms FY2025 sales outlook from $3.180 billion-$3.260 billion to $3.180 billion-$3.260 billion vs $3.225 billion estimate.

Posted In: AHCO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist